GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Procter & Gamble Health PGHL.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

5,699.50

+2.58%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2025

Revenue

₹14.08bn

FY2016FY2025

Net income

₹3.27bn

FY2016FY2025

Free cash flow

₹3.22bn

FY2016FY2025

Shareholders' equity

₹5.25bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue₹14.08bn₹12.18bn₹11.51bn₹12.30bn₹11.14bn₹11.55bn₹8.89bn₹8.49bn₹6.98bn₹9.93bn
Gross profit₹7.97bn₹8.69bn₹8.09bn₹8.46bn₹7.61bn₹7.75bn₹5.68bn₹5.74bn₹4.56bn₹5.72bn
Research and development₹73.6m₹26.1m₹38.6m₹57.1m₹65.5m—₹66.1m₹162.4m₹35.6m₹4.2m
Operating income₹4.50bn₹6.33bn₹5.37bn₹5.59bn₹4.77bn₹2.41bn₹3.14bn₹3.15bn₹2.45bn₹3.37bn
Net income₹3.27bn₹2.51bn₹2.01bn₹2.29bn₹1.93bn₹2.05bn₹1.66bn₹8.39bn₹939.1m₹791.3m
Diluted earnings per share196.94151.32121.03138.34115.92123.6599.96505.27552,411.7547.68

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets₹8.41bn₹7.94bn₹7.94bn₹11.01bn₹8.94bn—₹11.76bn₹17.59bn₹9.91bn₹8.83bn
Cash and short-term investments₹1.85bn₹1.89bn₹2.44bn₹4.53bn₹3.19bn—₹6.39bn₹12.43bn₹3.48bn₹3.07bn
Total liabilities₹3.17bn₹2.57bn₹2.56bn₹3.50bn₹2.77bn—₹2.70bn₹2.19bn₹2.58bn₹2.37bn
Debt₹92.9m₹76.2m₹95.6m₹120.0m₹28.3m—₹79.0m₹65.3m₹67.1m−₹44.2m
Shareholders' equity₹5.25bn₹5.37bn₹5.38bn₹7.51bn₹6.16bn—₹9.06bn₹15.40bn₹7.33bn₹6.45bn
Shares outstanding17m17m17m17m17m17m17m17m0m17m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations₹3.38bn₹1.76bn₹2.28bn₹2.36bn₹1.70bn—₹2.96bn−₹1.30bn₹536.6m₹1.07bn
Capital spending−₹155.1m−₹85.6m−₹217.3m−₹424.8m−₹379.2m—−₹232.7m−₹267.2m−₹303.0m−₹316.5m
Free cash flow₹3.22bn₹1.67bn₹2.07bn₹1.94bn₹1.32bn—₹2.73bn−₹1.57bn₹233.6m₹753.9m
Dividends paid−₹3.40bn−₹2.32bn−₹4.15bn−₹937.9m−₹2.84bn—−₹8.83bn−₹249.0m−₹182.6m−₹124.5m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₹3.64bn₹3.70bn₹3.74bn₹3.25bn₹3.39bn₹3.11bn₹3.10bn₹3.39bn
Gross profit₹2.67bn₹2.78bn₹1.96bn₹1.97bn₹2.45bn₹2.12bn₹2.34bn₹2.45bn
Operating income₹935.8m₹1.29bn₹1.09bn₹1.19bn₹889.3m₹786.6m₹1.87bn₹889.6m
Net income₹961.5m₹946.0m₹775.9m₹885.4m₹661.8m₹611.8m₹909.0m₹661.8m
Diluted earnings per share57.9256.9946.7453.3439.8736.8654.7639.87
Cash from operations———₹1.72bn—₹492.0m₹1.19bn—
Capital spending———−₹59.0m—−₹32.0m−₹53.0m—
Free cash flow———₹1.66bn—₹460.0m₹1.14bn—
Total assets—₹8.41bn—₹8.94bn—₹7.94bn₹8.70bn—
Cash and short-term investments₹1.85bn₹1.85bn₹2.86bn₹2.86bn₹1.89bn₹2.06bn₹2.92bn₹2.44bn
Debt—₹35.7m—₹62.0m—₹76.2m₹82.8m—
Shareholders' equity₹5.25bn₹5.25bn₹6.20bn₹6.20bn₹5.37bn₹5.37bn₹6.10bn₹5.38bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue4.6%4.0%4.1%
Operating income-7.0%13.3%5.1%
Net income12.5%9.8%19.8%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin63.4%66.3%66.8%64.6%
Operating margin41.3%43.5%39.8%37.6%
Net margin22.0%20.1%19.3%22.7%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2016FY2015
Price to earnings29.034.640.828.644.854.341.25.318.020.7
Price to sales6.77.17.15.37.79.77.75.21.41.2

Dividends and splits

Per share, in the currency the company pays

Paid for 13 years. Last went ex-dividend on 27 Aug 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2019FY2018
Paid in the year155.00125.00110.00145.0052.50132.0024.0015.00

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.